SequelSEC

Nkarta, Inc. NKTX

Pharmaceutical Preparations · CIK 0001787400 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2025-12-31
Operating income
Unavailable
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

This page shows 5 annual periods of income statement, balance sheet and cash flow figures normalized from Nkarta, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Nkarta, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312019-12-312019-09-302019-06-30
RevenueUnavailableUnavailable$0-$385$2.31K
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailable
Operating incomeUnavailableUnavailable-$8.65M-$5.91M-$4.67M
Net incomeUnavailableUnavailable-$10.49M-$2.67M-$4.84M
Research & developmentUnavailableUnavailable$6.68M$4.62M$3.62M
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailable$0$0$0
Diluted EPSUnavailableUnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrativeUnavailableUnavailable$1.97M$1.29M$1.05M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Nkarta, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312019-12-312019-09-302019-06-30
Cash & equivalents$39.63M$27.87M$20.61M$39.10M$5.91M
Total assets$404.21M$501.20M$48.41MUnavailableUnavailable
Current assets$282.51M$273.34M$37.46MUnavailableUnavailable
Total liabilities$91.88M$93.23M$14.08MUnavailableUnavailable
Current liabilities$22.27M$18.92M$8.16MUnavailableUnavailable
Total equity incl. NCI$312.32M$407.98M-$25.48M-$15.57M-$13.14M
Temporary (mezzanine) equityUnavailableUnavailable$59.82MUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$2.09M$638.00K$1.88MUnavailableUnavailable

Cash flow

Nkarta, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312019-12-312019-09-302019-06-30
Operating cash flowUnavailableUnavailable-$6.64M-$4.65MUnavailable
Capital expendituresUnavailableUnavailable$622.00K$601.20KUnavailable
Investing cash flowUnavailableUnavailable-$16.99M-$601.20KUnavailable
Financing cash flowUnavailableUnavailable$5.14M$38.43MUnavailable
Net change in cashUnavailableUnavailable-$18.49M$33.18MUnavailable
Stock-based compensationUnavailableUnavailable$565.00K$227.56K$100.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailable$100.00K$100.00K$100.00K

Derived

Nkarta, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312019-12-312019-09-302019-06-30
Free cash flowUnavailableUnavailable-$7.26M-$5.25MUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailable-202375.3%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailable4332.8%
Current ratio12.69x14.45x4.59xUnavailableUnavailable
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailable156882.9%
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NKTX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-12View SEC filing
10-K · Filed 2026-03-25View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.